<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02814890</url>
  </required_header>
  <id_info>
    <org_study_id>2011QD10</org_study_id>
    <nct_id>NCT02814890</nct_id>
  </id_info>
  <brief_title>Thoracic Paravertebral Block Using Ropivacaine and Dexmedetomidine</brief_title>
  <official_title>Thoracic Paravertebral Block Using Ropivacaine With/Without Dexmedetomidine in Video-assisted Pneumonectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jianghui Xu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Huashan Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of the study is whether dexmedetomidine plus local anesthetic ropivacaine
      could extend the pain relieve time compared with only ropivacaine when thoracic paravertebral
      block is performed at the end of video-assisted pneumonectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators aim to recruit 60 patients undergoing video-assisted pneumonectomy. All
      patients ASA physical status I-II grade, aged within 20-70 years, are randomly allocated into
      two groups: 75mg/20ml ropivacaine only group (Group R, n=30) and 75mg/20ml ropivacaine +
      1μg/kg dexmedetomidine (Group RD, n=30). At the end of surgery, the investigators perform
      four points thoracic paravertebral block guided by ultrasound combined with nerve stimulator
      at T3-4, T4-5, T5-6, T6-7 of surgical side where 5ml solution is injected to each point. The
      characteristics of patients are analyzed to confirm whether they are comparable in both
      groups. Pain was assessed according to a numerical rating scale (NRS) (0 = no pain; 10 =
      worst pain imaginable). Patients were asked to evaluate the maximal degree of pain. Pain
      scores were recorded in post anesthesia care unit(PACU), and1, 2,4, 8, 12, 24, 36 and 48
      hours after surgery. The study endpoints are evaluated by an anesthesiologist who does not
      know the group allocation. The postoperative rescue analgesic administration, adverse
      outcomes and patient satisfaction are also recorded.

      All data were processed in SPSS 18.0 (SPSS Inc., Chicago, IL USA). Normality was tested by
      the Kolmogorov-Smirnov analysis. Comparisons of continuous outcomes among groups were
      examined using Kruskal-Wallis test. Chi-square analysis or Fisher's exact test was used to
      assess categorical outcomes between groups. A P-value&lt;0.05 was considered statistically
      significant.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain (Pain scores) intensity measure</measure>
    <time_frame>self reported pain intensity measure for 2 days after surgery</time_frame>
    <description>pain numerical rating scales （NRS) at rest and coughing（0: no pain;10 :worst possible pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>Hour 48 after surgery</time_frame>
    <description>using a 5-point Likert scale (completely satisfied, quite satisfied,slightly dissatisfied, dissatisfied, and very dissatisfied)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative rescue analgesic administration</measure>
    <time_frame>Hour 24, Hour 48 after surgery</time_frame>
    <description>a rescue analgesic morphine 5mg will be administered for any pain score ≥4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse events</measure>
    <time_frame>Hour 48 after surgery</time_frame>
    <description>including nausea, vomiting, hypotension, bradycardia, and cardiac arrhythmia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Ropivacaine and dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Thoracic paravertebral block is performed using 75mg/20ml ropivacaine + 1μg/kg dexmedetomidine at the end of video-assisted pneumonectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ropivacaine only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Thoracic paravertebral block is performed using 75mg/20ml ropivacaine at the end of video-assisted pneumonectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Video-assisted Pneumonectomy</intervention_name>
    <description>Video-assisted Pneumonectomy under general anesthesia.</description>
    <arm_group_label>Ropivacaine and dexmedetomidine</arm_group_label>
    <arm_group_label>Ropivacaine only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Thoracic paravertebral block</intervention_name>
    <description>The procedure is guided by ultrasound combined with nerve stimulator at T3-4, T4-5, T5-6, T6-7 of surgical side.</description>
    <arm_group_label>Ropivacaine and dexmedetomidine</arm_group_label>
    <arm_group_label>Ropivacaine only</arm_group_label>
    <other_name>Thoracic paravertebral nerve block</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA physical status I-II grade

          -  Undergoing elective video-assisted pneumonectomy under general anesthesia.

        Exclusion Criteria:

          -  Refusal for paravertebral block

          -  Inability to obtain informed consent

          -  Coagulation disorders, neuropathy, or body mass index greater than 40 kg/m2

          -  Pregnancy

          -  Infections at the site of injection for the paravertebral block

          -  Allergy to local anesthetics or alpha-2 adrenergic agonists

          -  Heart block or bradycardia (heart rate &lt; 60 beat per minute)

          -  Clinically significant cardiovascular, pulmonary, renal, or hepatic diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jun Zhang, MD,PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anesthesiology,Huashan Hospital,Fudan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jun Zhang, MD,PhD</last_name>
    <phone>086-021-52889999</phone>
    <phone_ext>7693</phone_ext>
    <email>snapzhang@aliyun.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Huashan Hospital Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200040</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jun Zhang, MD,PhD</last_name>
      <phone>0086-021-52889999</phone>
      <phone_ext>7693</phone_ext>
      <email>snapzhang@aliyun.com</email>
    </contact>
    <investigator>
      <last_name>Jiang-Hui Xu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xiao-Yu Yang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xiao-Bing Hu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 21, 2016</study_first_submitted>
  <study_first_submitted_qc>June 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2016</study_first_posted>
  <last_update_submitted>August 19, 2016</last_update_submitted>
  <last_update_submitted_qc>August 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Huashan Hospital</investigator_affiliation>
    <investigator_full_name>Jianghui Xu</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Thoracic paravertebral block</keyword>
  <keyword>Dexmedetomidine</keyword>
  <keyword>Video-assisted Pneumonectomy</keyword>
  <keyword>Ropivacaine</keyword>
  <keyword>Pain, Postoperative</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>August 29, 2017</submitted>
    <returned>March 30, 2018</returned>
    <submitted>April 20, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

